Patents by Inventor Mark Mitchnick

Mark Mitchnick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230355661
    Abstract: The invention contemplates a copolymer which is a graft or block copolymer useful to change wettability and surface characteristics of biological surfaces. Methods for use of these formulations and coatings to change wettability and sterically stabilize, and lubricate biological surfaces in a subject, for example, in the treatment of dry eye syndrome, and to prevent adherence of unwanted proteins, for example in the treatment of contact lens intolerance, are provided.
    Type: Application
    Filed: July 17, 2023
    Publication date: November 9, 2023
    Inventors: Eugene Rex Cooper, David Maxwell Kleinman, Andrew Loxley, Mark A. Mitchnick
  • Patent number: 11793786
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: April 12, 2021
    Date of Patent: October 24, 2023
    Assignee: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • Publication number: 20230104144
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: December 6, 2022
    Publication date: April 6, 2023
    Applicant: Neurelis, Inc.
    Inventors: Steve CARTT, David MEDEIROS, Garry Thomas GWOZDZ, Andrew LOXLEY, Mark MITCHNICK, David F. HALE, Edward T. MAGGIO
  • Publication number: 20220304936
    Abstract: An amorphous solid dispersion includes a linear poly(acrylic acid) and an active pharmaceutical ingredient. The linear poly(acrylic acid) used to form the amorphous solid dispersion has a Brookfield viscosity of at least 100 cP at 25° C. A method of forming such an amorphous solid dispersion of an active pharmaceutical ingredient includes forming a liquid dispersion of a linear poly(acrylic acid), an active pharmaceutical ingredient, and a solvent system, the linear poly(acrylic acid) having a Brookfield viscosity at 25° C. of at least 100 cP and evaporating the solvent system from the liquid dispersion to form an amorphous solid dispersion.
    Type: Application
    Filed: August 28, 2020
    Publication date: September 29, 2022
    Applicant: LUBRIZOL ADVANCED MATERIALS, INC.
    Inventors: Elena S. Draganoiu, Barbara J. Morgan, David W. Weaver, Shreya P. Shah, Todd J. Wilson, Michael Grieco, Cynthia S. Randall, Kimberly A. Zubris, Mark A. Mitchnick, Liliana A. Miinea
  • Publication number: 20220241187
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: April 15, 2022
    Publication date: August 4, 2022
    Applicant: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • Publication number: 20220125715
    Abstract: A delivery device for active pharmaceutical agents and made up of a hollow polymeric outer shape forming at least one closed internal cavity or compartment and containing a solid core of one or more active pharmaceutical agents and one or more excipients substantially unattached to the hollow polymeric outer shape is provided. Also provided are methods for production and use of this device.
    Type: Application
    Filed: February 14, 2020
    Publication date: April 28, 2022
    Applicant: Particle Sciences Inc.
    Inventors: Jason L. McConnell, Mark A. Mitchnick, Bruce L. Frank, Onajite Okoh
  • Publication number: 20220117887
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: June 2, 2021
    Publication date: April 21, 2022
    Applicant: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David Hale, Edward T. Maggio
  • Publication number: 20220062227
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: April 12, 2021
    Publication date: March 3, 2022
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • Patent number: 11246831
    Abstract: Aqueous dispersions of chemically and physically stable particles for use in delivery of active pharmaceutical ingredients and processes for their production and use to enhance a biological response to an active pharmaceutical ingredient and prophylactically or therapeutically treat a subject are provided. Vaccines, wherein the active pharmaceutical ingredient is a solution of subunit vaccine antigen mixed with a colloidal dispersion of electrically charged particles and use of such vaccines in immunization are also provided.
    Type: Grant
    Filed: March 31, 2008
    Date of Patent: February 15, 2022
    Assignee: PARTICLE SCIENCES, INC.
    Inventors: Andrew Loxley, Mark Mitchnick, David Fairhurst, Christy Ann Eatmon
  • Patent number: 11241414
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: February 8, 2022
    Assignee: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • Publication number: 20220023334
    Abstract: The invention contemplates a copolymer which is a graft or block copolymer useful to change the ocular surface temperature and other characteristics of biological or contact lens surfaces. Methods for use of these formulations and coatings to increase the temperature of the skin, mucous membranes, eye or eyelids will help treat many conditions including blepharitis and non-healing ulcers. Methods to decrease evaporation, improve wettability and stabilize the tear film, and lubricate biological surfaces in a subject, for example, in the treatment of dry eye syndrome, and to improve contact lens tolerability, are provided.
    Type: Application
    Filed: October 5, 2021
    Publication date: January 27, 2022
    Inventors: Eugene Rex Cooper, David Maxwell Kleinman, Andrew Loxley, Mark Mitchnick
  • Publication number: 20210393672
    Abstract: The invention contemplates a copolymer which is a graft or block copolymer useful to change wettability and surface characteristics of biological surfaces. Methods for use of these formulations and coatings to change wettability and sterically stabilize, and lubricate biological surfaces in a subject, for example, in the treatment of dry eye syndrome, and to prevent adherence of unwanted proteins, for example in the treatment of contact lens intolerance, are provided.
    Type: Application
    Filed: September 1, 2021
    Publication date: December 23, 2021
    Inventors: Eugene Rex Cooper, David Maxwell Kleinman, Andrew Loxley, Mark A. Mitchnick
  • Patent number: 11135242
    Abstract: The invention contemplates a copolymer which is a graft or block copolymer useful to change the ocular surface temperature and other characteristics of biological or contact lens surfaces. Methods for use of these formulations and coatings to increase the temperature of the skin, mucous membranes, eye or eyelids will help treat many conditions including blepharitis and non-healing ulcers. Methods to decrease evaporation, improve wettability and stabilize the tear film, and lubricate biological surfaces in a subject, for example, in the treatment of dry eye syndrome, and to improve contact lens tolerability, are provided.
    Type: Grant
    Filed: January 7, 2019
    Date of Patent: October 5, 2021
    Assignee: Calm Water Therapeutics LLC
    Inventors: Eugene Rex Cooper, David Maxwell Kleinman, Andrew Loxley, Mark Mitchnick
  • Publication number: 20210299089
    Abstract: The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.
    Type: Application
    Filed: May 27, 2021
    Publication date: September 30, 2021
    Applicant: Neurelis, Inc.
    Inventors: Steve Cartt, David Medeiros, Garry Thomas Gwozdz, Andrew Loxley, Mark Mitchnick, David F. Hale, Edward T. Maggio
  • Publication number: 20210304867
    Abstract: The present technology pertains an application configured to instruct a user to think about an aspect of a craving to partake in an undesired behavior, and after the presentation of the information presenting a user interface instructing the user to think about the aspect of the craving to partake in the undesired behavior. The user interface of the application can present an interface that is configured to receive a craving score that is an indication of how the craving to partake in the undesired behavior has changed relative to a time prior to the presentation of the information instructing the user to think about the aspect of the craving to partake in the undesired behavior. The present technology can proactively adjust to help a user to take helpful actions towards behavior change.
    Type: Application
    Filed: March 27, 2020
    Publication date: September 30, 2021
    Inventors: Judson Brewer, Mark Mitchnick, Joshua Roman
  • Patent number: 11110119
    Abstract: The invention contemplates a copolymer which is a graft or block copolymer useful to change wettability and surface characteristics of biological surfaces. Methods for use of these formulations and coatings to change wettability and sterically stabilize, and lubricate biological surfaces in a subject, for example, in the treatment of dry eye syndrome, and to prevent adherence of unwanted proteins, for example in the treatment of contact lens intolerance, are provided.
    Type: Grant
    Filed: July 27, 2020
    Date of Patent: September 7, 2021
    Assignee: Calm Water Therapeutics LLC
    Inventors: Eugene Rex Cooper, David Maxwell Kleinman, Andrew Loxley, Mark A. Mitchnick
  • Patent number: 10888625
    Abstract: A targeted drug delivery complex containing a particle, a targeting moiety electrostatically attached to the particle, and an active pharmaceutical ingredient attached to or dispersed or dissolved within the particle is provided. Also provided are pharmaceutical formulations containing a plurality of the complexes as well as methods for use in targeting an active pharmaceutical ingredient to a selected cell or tissue and production of such formulations.
    Type: Grant
    Filed: October 29, 2013
    Date of Patent: January 12, 2021
    Assignee: PARTICLE SCIENCES, INC.
    Inventors: Mark Mitchnick, Garry Gwozdz, Andrew Loxley
  • Publication number: 20200375890
    Abstract: The disclosed technology provides an improved drug delivery device which is easily implantable and removable, as well as method of using and making the same. The described drug delivery device includes: (a) a wall comprising at least in part a polymeric composition, which surrounds and forms; (b) a compartment; (c) a drug composition in the compartment which includes an active agent; (d) at least one passageway in the wall for releasing the active agent from said drug composition to said environment of use. The device (i) can be implanted in an environment of use, (ii) is able to maintain its structural integrity for a period of use to allow for the release of the active agent, and (iii) can then be removed from the environment of use.
    Type: Application
    Filed: March 16, 2018
    Publication date: December 3, 2020
    Inventors: Mark A. Mitchnick, Kimberly A. Zubris, Brett Braker
  • Publication number: 20200352984
    Abstract: The invention contemplates a copolymer which is a graft or block copolymer useful to change wettability and surface characteristics of biological surfaces. Methods for use of these formulations and coatings to change wettability and sterically stabilize, and lubricate biological surfaces in a subject, for example, in the treatment of dry eye syndrome, and to prevent adherence of unwanted proteins, for example in the treatment of contact lens intolerance, are provided.
    Type: Application
    Filed: July 27, 2020
    Publication date: November 12, 2020
    Inventors: Eugene Rex Cooper, David Maxwell Kleinman, Andrew Loxley, Mark A. Mitchnick
  • Patent number: 10729715
    Abstract: The invention contemplates a copolymer which is a graft or block copolymer useful to change wettability and surface characteristics of biological surfaces. Methods for use of these formulations and coatings to change wettability and sterically stabilize, and lubricate biological surfaces in a subject, for example, in the treatment of dry eye syndrome, and to prevent adherence of unwanted proteins, for example in the treatment of contact lens intolerance, are provided.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: August 4, 2020
    Assignee: Eyeon Particle Sciences LLC
    Inventors: Eugene Rex Cooper, David Maxwell Kleinman, Andrew Loxley, Mark A. Mitchnick